Yoshiki Murakumo

10PUBLICATIONS
10CO-AUTHORS
Molecular imaging (incl. electron microscopy and neutron diffraction)Solid tumoursPredictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 28, 2026
Molecular Hydrogen Attenuates Chronic Inflammation and Delays the Onset of Ultraviolet B-Induced Skin Carcinogenesis in Mice.

Fumiko Hori, Sayaka Sobue, Chisato Inoue

|Jan 23, 2026
Two Giant Cystic Uterine Adenomyomas in a Premenopausal Woman: The Largest Case to Date With Immunohistochemical Findings.

Kazuhisa Kitami, Toshihide Matsumoto, Seigi Furukawa

|Jan 12, 2026
CD109 Expression in Tumor and Stromal Cells Serves as a Prognostic Biomarker for Tumor Progression and Outcome in Gallbladder Adenocarcinoma.

Taro Kogami, Masaaki Ichinoe, Yasutaka Sakurai

|Jun 04, 2025
REV7 subunit of mutagenic DNA polymerase ζ as a predictive biomarker for the efficacy of immune checkpoint inhibitor therapy in melanoma.

Akiyoshi Hoshino, Koya Obara, Masaaki Ichinoe

|Dec 31, 2024
High levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma.

Yurika Kesen, Masaaki Ichinoe, Shoko Hayashi

|Dec 22, 2023
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.

Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai

Pageof 2

Frequent Collaborators

3 joint publications

Masaaki Ichinoe

1 joint publications

Tetsuro Taki

1 joint publications

Atsushi Enomoto

1 joint publications

Shinji Mii